SCHEDULE: Franklin Resources Exits Adverum Bio Stake

Sentiment:

Ownership Change Report 5 August 2025 11:51 AM

📋All filings for Adverum Biotechnologies, INC

Franklin Resources, Inc. and its principals report zero beneficial ownership in Adverum Biotechnologies, Inc., signaling a complete divestment.

Worse than expectedFranklin Resources, Inc., a significant institutional investor, along with Charles B. Johnson and Rupert H. Johnson, Jr., have reported 0% beneficial ownership in Adverum Biotechnologies, Inc., indicating a complete divestment of their previously held stake. This exit by a major investor can be perceived negatively by the market.

Summary

This is an Amendment No. 1 to a Schedule 13G filing for Adverum Biotechnologies, Inc. common stock.
Franklin Resources, Inc., Charles B. Johnson, and Rupert H. Johnson, Jr. are the reporting persons.
As of June 30, 2025, the reporting persons beneficially own 0 shares of Adverum Biotechnologies, Inc. common stock.
This represents 0.0% of the class of securities.
The filing indicates a complete divestment of their previously held stake in the company.

Sentiment

Score: 3

Explanation: The complete divestment of shares by a major institutional investor like Franklin Resources, Inc. could be interpreted as a negative signal regarding the company's future prospects or the investor's portfolio strategy.

Future Outlook

Industry Context

This filing indicates that a major institutional investor, Franklin Resources, has fully exited its position in Adverum Biotechnologies, Inc. This action could be part of a broader portfolio rebalancing strategy or reflect a specific investment decision regarding the biotechnology sector or Adverum's individual prospects.

Stakeholder Impact

Shareholders: May react negatively to the news of a major institutional investor divesting, potentially leading to downward pressure on the stock price.

Key Dates

Date	Description
2023-12-11	Date of Limited Power of Attorney for Charles B. Johnson and Rupert H. Johnson, Jr.
2025-06-30	Date of event requiring the filing of this statement (ownership snapshot date).
2025-08-01	Date of filing with the SEC.

Recommendation

sell

The complete divestment by Franklin Resources, Inc., a significant institutional investor, suggests a lack of confidence or a strategic shift away from Adverum Biotechnologies, Inc. Such a move by a large holder often signals potential headwinds or a re-evaluation of the company's prospects, warranting a cautious or negative stance for investors.

Keywords

Adverum Biotechnologies, Franklin Resources, Institutional Ownership, Divestment, Schedule 13G, Biotech, Investment Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.